Metraipolis › archive › dc_4eaa77bff0ca

Factors influencing pharmaceutical companies' decisions to pursue compassionate use programs in the EU: a qualitative study in The Netherlands — Europe PMC PMID:41509652

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41509652
DOI
10.1080/20523211.2025.2605391
License (as archived)
solo-consultazione
Archived
2026-11-07T01:14:41.490Z
SHA-256 of the archived text
728e9bef57954624e1131db727975678857ce1d04898a58489394941216385d2
Stable URL of this page
https://metraipolis.com/documento/dc_4eaa77bff0ca

How to cite

Factors influencing pharmaceutical companies' decisions to pursue compassionate use programs in the EU: a qualitative study in The Netherlands — Europe PMC PMID:41509652 — Europe PMC (en), https://europepmc.org/article/MED/41509652 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4eaa77bff0ca (Metraipolis archive dc_4eaa77bff0ca, sha256 728e9bef57954624e1131db727975678857ce1d04898a58489394941216385d2)
BibTeX
@misc{dc4eaa77bff0ca,
  title = {Factors influencing pharmaceutical companies' decisions to pursue compassionate use programs in the EU: a qualitative study in The Netherlands — Europe PMC PMID:41509652},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41509652},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4eaa77bff0ca; sha256 728e9bef57954624e1131db727975678857ce1d04898a58489394941216385d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41509652. Agents can read the archived copy with the MCP tool read_document.